Allen Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Sell
22,464
-6,576
-23% -$172K 0.26% 40
2026
Q1
$815K Sell
29,040
-2,262
-7% -$60.2K 0.41% 36
2025
Q4
$779K Sell
31,302
-4,353
-12% -$110K 0.47% 37
2025
Q3
$908K Sell
35,655
-55,731
-61% -$1.38M 0.62% 31
2025
Q2
$2.22M Sell
91,386
-1,130
-1% -$26.4K 1.55% 12
2025
Q1
$2.34M Buy
92,516
+5,280
+6% +$138K 1.61% 10
2024
Q4
$2.31M Sell
87,236
-11,703
-12% -$317K 1.66% 11
2024
Q3
$2.86M Buy
98,939
+14,487
+17% +$423K 1.99% 9
2024
Q2
$2.36M Sell
84,452
-1,676
-2% -$46.1K 2.1% 10
2024
Q1
$2.39M Buy
86,128
+8,879
+11% +$246K 2.11% 9
2023
Q4
$2.22M Buy
+77,249
New +$2.34M 2.18% 11

Other funds holding PFE

Allen Wealth Management's PFE Position: Q2 2026 in Review

Allen Wealth Management reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $172K and leaving 22,464 shares worth $541K. The position accounts for 0.26% of the portfolio, ranked #40.

Allen Wealth Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.86M in Q3 2024. 1,265 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Allen Wealth Management held 22,464 shares of Pfizer worth $541K as of Q2 2026.
  • Allen Wealth Management sold 6,576 Pfizer shares in Q2 2026, an estimated $172K.
  • Pfizer made up 0.26% of Allen Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Allen Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Allen Wealth Management's Pfizer position peaked at $2.86M in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.